Sipp Industries, Inc. (SIPC) has announced the launch of its Nano CBN Drops aimed at the expanding sleep aid market. These drops feature high-grade nano emulsified CBN, promoting benefits like anti-inflammatory properties and improved sleep quality. Available in 100mg and 200mg dosages, they are water-soluble for better absorption. With a significant portion of older adults suffering from insomnia, the product addresses a critical health issue. Sipp Industries plans to market these drops globally, leveraging both online and traditional distribution channels.
Sipp Industries has appointed Jakob Jorgensen as the new Interim CEO, bringing extensive management experience in the cannabis industry. Jorgensen has nine years of expertise in high-volume dispensaries and extraction facilities across states like Nevada and California. He co-founded Calypso Extracts and Green Thumb Beverages, implementing innovative technologies for cannabinoid micronization. Sipp Industries has acquired a minority stake in Calypso and plans to launch new products next month, enhancing its market presence.
Sipp Industries (OTC Pink: SIPC) has announced its exclusive role in providing hardware, packaging, and containers for Calypso Extracts' nano emulsion products. Following a minority ownership interest in Calypso, Sipp will supply raw materials for the brand's expansion in Oklahoma's cannabis market. Initial products include flavorless White Lightning Syringes, Thunder Drops enhancer in various flavors, and health-focused Fire Water Shots. The collaboration is expected to launch next month through major distributor Argent Cannabis, with multiple dispensaries expressing enthusiasm.
Sipp Industries has acquired a 5% stake in Calypso Extracts, an Oklahoma-based company, with the option to increase to 10% within a year. This deal provides access to over 2,000 dispensaries through a partnership with Argent Cannabis, enhancing growth potential in the cannabis market. Calypso, known for its proprietary nano emulsion process, produces a variety of cannabis products and is nearing approval for its manufacturing license. CEO Nick Pelletiere expresses optimism about revenue generation and strategic alignment.